105 related articles for article (PubMed ID: 31255902)
1. The role of atopy in the pathogenesis of bleomycin pulmonary toxicity.
Ozyigit LP; Aktas EC; Senbas ZA; Ozturk AB; Ozturk E; Ergonul MO; Tabak L; Ferhanoglu B; Cetiner M; Deniz G
Respir Med; 2019 Aug; 155():1-5. PubMed ID: 31255902
[TBL] [Abstract][Full Text] [Related]
2. Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma.
Sun HL; Atenafu EG; Tsang R; Kukreti V; Marras TK; Crump M; Kuruvilla J
Leuk Lymphoma; 2017 Nov; 58(11):2607-2614. PubMed ID: 28504035
[TBL] [Abstract][Full Text] [Related]
3. The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor
Andersen MD; Kamper P; d'Amore A; Clausen M; Bentzen H; d'Amore F
Leuk Lymphoma; 2019 Apr; 60(4):927-933. PubMed ID: 30277120
[TBL] [Abstract][Full Text] [Related]
4. Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma.
Martin WG; Ristow KM; Habermann TM; Colgan JP; Witzig TE; Ansell SM
J Clin Oncol; 2005 Oct; 23(30):7614-20. PubMed ID: 16186594
[TBL] [Abstract][Full Text] [Related]
5. Advancing age and the risk of bleomycin pulmonary toxicity in a largely older cohort of patients with newly diagnosed Hodgkin Lymphoma.
Thomas TS; Luo S; Reagan PM; Keller JW; Sanfilippo KM; Carson KR
J Geriatr Oncol; 2020 Jan; 11(1):69-74. PubMed ID: 31668826
[TBL] [Abstract][Full Text] [Related]
6. Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?
Abou Yehia Z; Mikhaeel GN; Smith G; Pinnix CC; Milgrom SA; Tang C; Jiang W; Fanale MA; Oki Y; Shank JH; Horace T; Reddy J; Akhtari M; Gunther JR; Suki T; Allen PK; Turner S; Mawlawi O; Dabaja BS
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):951-958. PubMed ID: 27742539
[TBL] [Abstract][Full Text] [Related]
7. Bleomycin induced pulmonary toxicity in patients with germ cell tumours.
Usman M; Faruqui ZS; ud Din N; Zahid KF
J Ayub Med Coll Abbottabad; 2010; 22(3):35-7. PubMed ID: 22338413
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin's lymphoma.
Al-Jizani WA; Al-Mansour MM; Al-Fayea TM; Shafi RU; Kazkaz GA; Bayer AM; Al-Foheidi ME; Ibrahim EM
Future Oncol; 2015; 11(15):2149-57. PubMed ID: 26235180
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.
Maruyama Y; Sadahira T; Mitsui Y; Araki M; Wada K; Tanimoto R; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
Med Oncol; 2018 Apr; 35(6):80. PubMed ID: 29700638
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of bleomycin hydrolase by caspase-3 during apoptosis.
Chen Y; Xu R; Chen J; Li X; He Q
Oncol Rep; 2013 Aug; 30(2):939-44. PubMed ID: 23708668
[TBL] [Abstract][Full Text] [Related]
11. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours.
O'Sullivan JM; Huddart RA; Norman AR; Nicholls J; Dearnaley DP; Horwich A
Ann Oncol; 2003 Jan; 14(1):91-6. PubMed ID: 12488299
[TBL] [Abstract][Full Text] [Related]
12. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman.
Ahmed BM; Al-Zakwani IS
J Oncol Pharm Pract; 2013 Mar; 19(1):3-7. PubMed ID: 22504168
[TBL] [Abstract][Full Text] [Related]
13. Action of bleomycin is affected by bleomycin hydrolase but not by caveolin-1.
Chen J; Chen Y; He Q
Int J Oncol; 2012 Dec; 41(6):2245-52. PubMed ID: 23076812
[TBL] [Abstract][Full Text] [Related]
14. Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma.
Jóna Á; Miltényi Z; Póliska S; Bálint BL; Illés Á
PLoS One; 2016; 11(6):e0157651. PubMed ID: 27327270
[TBL] [Abstract][Full Text] [Related]
15. The effect of concomitant use of Colony-Stimulating factors on bleomycin pulmonary toxicity - A systematic review and meta-analysis.
Mahdi Seyedzadeh Sani S; Sahranavard M; Jannati Yazdanabad M; Seddigh Shamsi M; Elyasi S; Hooshang Mohammadpour A; Sathyapalan T; Arasteh O; Ghavami V; Sahebkar A
Int Immunopharmacol; 2022 Nov; 112():109227. PubMed ID: 36099787
[TBL] [Abstract][Full Text] [Related]
16. Diffusion Lung Capacity Changes In Hodgkin Lymphoma Patients Before And After Abvd Chemotherapy.
Abdullah M; Alam S; Zafar W; Majid A
J Ayub Med Coll Abbottabad; 2016; 28(2):289-292. PubMed ID: 28718544
[TBL] [Abstract][Full Text] [Related]
17. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury.
Smith RE; Strieter RM; Phan SH; Lukacs N; Kunkel SL
J Leukoc Biol; 1998 Oct; 64(4):528-36. PubMed ID: 9766634
[TBL] [Abstract][Full Text] [Related]
18. Risk of pulmonary toxicity of bleomycin and filgrastim.
Laprise-Lachance M; Lemieux P; Grégoire JP
J Oncol Pharm Pract; 2019 Oct; 25(7):1638-1644. PubMed ID: 30319063
[TBL] [Abstract][Full Text] [Related]
19. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast proliferation by bleomycin stimulated peripheral blood mononuclear cell factors.
Yamamoto T; Katayama I; Nishioka K
J Rheumatol; 1999 Mar; 26(3):609-15. PubMed ID: 10090171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
